Given the known positive effects of both GH/IGF-1 axis and SST on cartilage repair, pain and function in the knee, we hypothesized that REG-O3 could be a disease-modifying osteoarthritis drug (DMOAD) for knee osteoarthritis (OA). The gene discussed is IGF1; the disease is osteoarthritis, knee.